Richard C. Hubbard

Comparison of once-daily and twice-daily administration of celecoxib for the treatment of osteoarthritis of the knee.

R. Hubbard, G. Geis, G. Williams, 2001, Clinical therapeutics.

Upper gastrointestinal safety evaluation of parecoxib sodium, a new parenteral cyclooxygenase-2-specific inhibitor, compared with ketorolac, naproxen, and placebo.

M. Kuss, R. Hubbard, J. Goldstein, 2001, Clinical therapeutics.